Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
35.13
-0.23 (-0.65%)
Sep 29, 2026, 10:20 AM EDT - Market open
Genmab Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +13.86% | Sep 14, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 → $42 | Buy | Maintains | $40 → $42 | +19.56% | Aug 7, 2026 |
| Jefferies | Jefferies | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $33 → $35 | Hold | Maintains | $33 → $35 | -0.37% | Aug 7, 2026 |
| Barclays | Barclays | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.